207 related articles for article (PubMed ID: 30298203)
1. Effects of age, HIV, and HIV-associated clinical factors on neuropsychological functioning and brain regional volume in HIV+ patients on effective treatment.
Gawron N; Choiński M; Szymańska-Kotwica B; Pluta A; Sobańska M; Egbert AR; Desowska A; Wolak T; Horban A; Firląg-Burkacka E; Bieńkowski P; Sienkiewicz-Jarosz H; Scińska-Bieńkowska A; Biswal B; Rao SM; Bornstein R; Łojek E
J Neurovirol; 2019 Feb; 25(1):9-21. PubMed ID: 30298203
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.
Behrman-Lay AM; Paul RH; Heaps-Woodruff J; Baker LM; Usher C; Ances BM
J Neurovirol; 2016 Feb; 22(1):93-103. PubMed ID: 26306688
[TBL] [Abstract][Full Text] [Related]
3. Initiation of antiretroviral therapy after the critical neuronal developmental period of the second postnatal year affects white matter microstructure in adolescents living with HIV.
Hoare J; Heany SJ; Fouche JP; Phillips N; Joska JA; Myer L; Zar HJ; Stein DJ
J Neurovirol; 2019 Apr; 25(2):254-262. PubMed ID: 30617850
[TBL] [Abstract][Full Text] [Related]
4. Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.
Ortega M; Brier MR; Ances BM
AIDS; 2015 Mar; 29(6):703-12. PubMed ID: 25849834
[TBL] [Abstract][Full Text] [Related]
5. White matter damage, neuroinflammation, and neuronal integrity in HAND.
Alakkas A; Ellis RJ; Watson CW; Umlauf A; Heaton RK; Letendre S; Collier A; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Kallianpur A; Gianella S; Marcotte T; Grant I; Fennema-Notestine C;
J Neurovirol; 2019 Feb; 25(1):32-41. PubMed ID: 30291567
[TBL] [Abstract][Full Text] [Related]
6. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B;
J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
Sanford R; Ances BM; Meyerhoff DJ; Price RW; Fuchs D; Zetterberg H; Spudich S; Collins DL
Clin Infect Dis; 2018 Nov; 67(11):1697-1704. PubMed ID: 29697762
[TBL] [Abstract][Full Text] [Related]
8. Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era.
Guha A; Brier MR; Ortega M; Westerhaus E; Nelson B; Ances BM
J Acquir Immune Defic Syndr; 2016 Dec; 73(4):374-383. PubMed ID: 27454251
[TBL] [Abstract][Full Text] [Related]
9. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60.
Guha A; Wang L; Tanenbaum A; Esmaeili-Firidouni P; Wendelken LA; Busovaca E; Clifford K; Desai A; Ances BM; Valcour V
J Neurovirol; 2016 Feb; 22(1):80-7. PubMed ID: 26265137
[TBL] [Abstract][Full Text] [Related]
11. Neurocognitive impairment and gray matter volume reduction in HIV-infected patients.
Kato T; Yoshihara Y; Watanabe D; Fukumoto M; Wada K; Nakakura T; Kuriyama K; Shirasaka T; Murai T
J Neurovirol; 2020 Aug; 26(4):590-601. PubMed ID: 32572834
[TBL] [Abstract][Full Text] [Related]
12. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
[TBL] [Abstract][Full Text] [Related]
13. HIV infection and age effects on striatal structure are additive.
O'Connor EE; Zeffiro T; Lopez OL; Becker JT; Zeffiro T
J Neurovirol; 2019 Aug; 25(4):480-495. PubMed ID: 31028692
[TBL] [Abstract][Full Text] [Related]
14. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood.
Ruiz-Saez B; García MM; de Aragon AM; Gil-Correa M; Melero H; Malpica NA; de Ory SJ; Zamora B; Guillen S; Rojo P; Falcon-Neyra L; Alvarez A; Fernandez P; Lorente-Jareño ML; Ramos JT; Sainz T; Velo C; Navarro ML; Gonzalez-Tomé MI;
Medicine (Baltimore); 2021 Apr; 100(15):e25403. PubMed ID: 33847637
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
Nichols SL; Bethel J; Kapogiannis BG; Li T; Woods SP; Patton ED; Ren W; Thornton SE; Major-Wilson HO; Puga AM; Sleasman JW; Rudy BJ; Wilson CM; Garvie PA;
J Neurovirol; 2016 Apr; 22(2):218-30. PubMed ID: 26463526
[TBL] [Abstract][Full Text] [Related]
16. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
Sanford R; Fellows LK; Ances BM; Collins DL
JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
[TBL] [Abstract][Full Text] [Related]
17. Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age.
Pfefferbaum A; Rosenbloom MJ; Sassoon SA; Kemper CA; Deresinski S; Rohlfing T; Sullivan EV
Biol Psychiatry; 2012 Sep; 72(5):361-70. PubMed ID: 22458948
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.
Carvalhal A; Gill MJ; Letendre SL; Rachlis A; Bekele T; Raboud J; Burchell A; Rourke SB;
J Neurovirol; 2016 Jun; 22(3):349-57. PubMed ID: 26572786
[TBL] [Abstract][Full Text] [Related]
19. Similar neurocognitive outcomes after 48 weeks in HIV-1-infected participants randomized to continue tenofovir/emtricitabine + atazanavir/ritonavir or simplify to abacavir/lamivudine + atazanavir.
Robertson K; Maruff P; Ross LL; Wohl D; Small CB; Edelstein H; Shaefer MS
J Neurovirol; 2019 Feb; 25(1):22-31. PubMed ID: 30298202
[TBL] [Abstract][Full Text] [Related]
20. Cocaine dependence does not contribute substantially to white matter abnormalities in HIV infection.
Cordero DM; Towe SL; Chen NK; Robertson KR; Madden DJ; Huettel SA; Meade CS
J Neurovirol; 2017 Jun; 23(3):441-450. PubMed ID: 28251596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
